Evidence map›Paper›PMID 41462110›Full record

ArticleScientific reports2025

Viable cell density as an indicator for dynamic feeding strategy in fed-batch and perfusion CHO cell culture.

Takuya Kikuchi, Shunsuke Ohira, Hideto Yamaguchi

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Takuya KikuchiCMC Development, Chemical & Biological Labs, Astellas Pharma, Inc, 5-2-3, Tokodai, Tsukuba-shi, 300-2698, Ibaraki, Japan. takuya.kikuchi@astellas.com.ORCID 0009-0008-9320-5553
Shunsuke OhiraCMC Development, Chemical & Biological Labs, Astellas Pharma, Inc, 5-2-3, Tokodai, Tsukuba-shi, 300-2698, Ibaraki, Japan.ORCID 0009-0003-0344-0933
Hideto YamaguchiCMC Development, Chemical & Biological Labs, Astellas Pharma, Inc, 5-2-3, Tokodai, Tsukuba-shi, 300-2698, Ibaraki, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The general approach to industrial production of monoclonal antibodies is fed-batch culture using Chinese Hamster Ovary (CHO) cells. Perfusion culture is also attracting attention as a next-generation culture method. In these culture methods, optimization of amino acid and glucose concentration in the culture medium is essential, and influences cell proliferation, viability, productivity, and monoclonal antibody quality. Further, the maintenance of optimal nutrient levels - by avoiding both depletion and accumulation - is crucial. This study aimed to develop a dynamic feeding strategy based on specific indicators to maintain optimal amino acid and glucose concentrations. Multivariate correlation analysis confirmed a strong relationship between nutrient consumption and viable cell density (VCD). Regression analysis was used to establish a regression model to estimate amino acid and glucose consumption based on VCD. Using this model, the nutrient composition of feed media for both fed-batch and perfusion cultures was adjusted, and a dynamic feeding strategy guided by VCD was evaluated. The observed nutrient concentration trends closely matched the model's predictions, confirming that VCD is a reliable indicator for implementing dynamic feeding. In both fed-batch and perfusion cultures, the VCD-guided dynamic feeding strategy enables the maintenance of multiple amino acids and glucose at target concentrations.

Indexed as

Batch Cell Culture TechniquesCell Culture TechniquesAmino AcidsAnimalsCell CountCell ProliferationCell SurvivalCHO CellsCricetinaeCricetulusCulture MediaGlucosePerfusionAmino AcidsCulture MediaGlucoseCHO cellDynamic feedingFed-batch cultureFeed media developmentPerfusion culture

Identifiers

PMID41462110
PMCPMC12749995

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.